Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Normative data and long-term test-retest reliability of the triple stimulation technique (TST) in multiple sclerosis.
Spring cleaning: time to rethink imaging research lines in MS?
Temporal aspects of visual perception in demyelinative diseases.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Oral BG-12 in multiple sclerosis.
Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in Relapsing-Remitting Multiple Sclerosis.
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time.
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study.
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Italian validation of the 12-item multiple sclerosis walking scale.
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial.
Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis.
Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
Tumefactive demyelination presenting during bevacizumab treatment.
Oligoclonal band status in scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
New hope for multiple sclerosis patients.
Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair.

Pages